Expert in Early Phase Therapeutics Joins NYU Langone Health as Associate Director for Clinical Research at Perlmutter Cancer Center

Janice M. Mehnert, MD, a nationally recognized expert in early phase therapeutics and the treatment of skin malignancies, has been appointed associate director for clinical research at NYU Langone Health’s Perlmutter Cancer Center. She assumes her post July 1, 2020.

Read more

Health System in Pandemic Epicenter Identifies Outcomes and New Risk Factors of Patients Hospitalized with COVID-19

A team of investigators at NYU Langone Health determined that just over half of 5,279 patients who tested positive for COVID-19 were hospitalized — and nearly a quarter of those hospitalized died or were discharged to hospice, including 60 percent who required ventilators.

Read more

Renowned Bioethicist Co-Chairs Effort to Help Cities Safely Reopen Sports and Recreation Amidst Pandemic

Arthur L. Caplan, PhD, the Drs. William F and Virginia Connolly Mitty Professor of Bioethics at NYU Langone Health and the founding director of the Division of Medical Ethics in the Department of Population Health, is co-chairing a newly-created United States Conference of Mayors (USCM) Advisory Panel on Sports, Recreation, and Health.

Read more

Dr. Mark B. Pochapin Elected President of the American College of Gastroenterology

Dr. Mark B. Pochapin, a gastroenterologist at NYU School of Medicine/NYU Langone Health, was elected President of the American College of Gastroenterology. Dr. Pochapin’s clinical and research interests include prevention, early detection, and treatment of gastrointestinal cancers and quality in endoscopy.

Read more